Skip Navigation
Skip to contents

Int J Stem Cells.  2021 Aug;14(3):341-350. 10.15283/ijsc21001.

MiR-181a Promotes Spermatogenesis by Targeting the S6K1 Pathway

Affiliations
  • 1Reproductive Medical Center, Zaozhuang Maternal and Child Health Hospital, Zaozhuang, China
  • 2Department of Gynaecology, Zaozhuang Maternal and Child Health Hospital, Zaozhuang, China
  • 3Reproductive Medical Center, Qingdao Women and Children’s Hospital, Qingdao University, Qingdao, China

Abstract

Approximately 15% of couples suffer from infertility worldwide, and male factors contribute to about 30% of total sterility cases. However, there is little progress in treatments due to the obscured understanding of underlying mechanisms. Recently microRNAs have emerged as a key player in the process of spermatogenesis. Expression profiling of miR-181a was carried out in murine testes and spermatocyte culture system. In vitro cellular and biochemical assays were used to examine the effect of miR-181a and identify its target S6K1, as well as elucidate the function with chemical inhibitor of S6K1. Human testis samples analysis was employed to validate the findings. miR-181a level was upregulated during mouse spermatogenesis and knockdown of miR-181a attenuated the cell proliferation and G1/S arrest and increased the level of S6K1, which was identified as a downstream target of miR-181a. Overexpression of S6K1 also led to growth arrest of spermatocytes while inhibitor of S6K1 rescued the miR-181a knockdown-mediated cell proliferation defect. In human testis samples of azoospermia patients, low level of miR-181a was correlated with defects in the spermatogenic process. miR-181a is identified as a new regulator and high level of miR-181a contributes to spermatogenesis via targeting S6K1.

Keyword

MiR-181a; Spermatogenesis; Male infertility; S6K1
Full Text Links
  • IJSC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr